1. Home
  2. GEL vs MNKD Comparison

GEL vs MNKD Comparison

Compare GEL & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • MNKD
  • Stock Information
  • Founded
  • GEL 1996
  • MNKD 1991
  • Country
  • GEL United States
  • MNKD United States
  • Employees
  • GEL N/A
  • MNKD N/A
  • Industry
  • GEL Oil Refining/Marketing
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • MNKD Health Care
  • Exchange
  • GEL Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • GEL 1.6B
  • MNKD 1.6B
  • IPO Year
  • GEL 1996
  • MNKD 2004
  • Fundamental
  • Price
  • GEL $14.16
  • MNKD $4.54
  • Analyst Decision
  • GEL Buy
  • MNKD Buy
  • Analyst Count
  • GEL 3
  • MNKD 6
  • Target Price
  • GEL $16.50
  • MNKD $8.92
  • AVG Volume (30 Days)
  • GEL 684.8K
  • MNKD 2.2M
  • Earning Date
  • GEL 05-01-2025
  • MNKD 05-07-2025
  • Dividend Yield
  • GEL 4.82%
  • MNKD N/A
  • EPS Growth
  • GEL N/A
  • MNKD N/A
  • EPS
  • GEL N/A
  • MNKD 0.10
  • Revenue
  • GEL $2,966,216,000.00
  • MNKD $285,504,000.00
  • Revenue This Year
  • GEL N/A
  • MNKD $14.23
  • Revenue Next Year
  • GEL $1.12
  • MNKD $14.56
  • P/E Ratio
  • GEL N/A
  • MNKD $45.40
  • Revenue Growth
  • GEL N/A
  • MNKD 43.50
  • 52 Week Low
  • GEL $9.86
  • MNKD $3.97
  • 52 Week High
  • GEL $16.44
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • GEL 53.01
  • MNKD 28.12
  • Support Level
  • GEL $13.60
  • MNKD $4.34
  • Resistance Level
  • GEL $14.01
  • MNKD $4.72
  • Average True Range (ATR)
  • GEL 0.76
  • MNKD 0.21
  • MACD
  • GEL -0.14
  • MNKD -0.01
  • Stochastic Oscillator
  • GEL 55.31
  • MNKD 27.03

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: